Patent: 10,113,000
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,113,000
Title: | Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
Abstract: | New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin\'s lymphomas. |
Inventor(s): | Grillo-Lopez; Antonio J. (South San Francisco, CA) |
Assignee: | Biogen Inc. (Cambridge, MA) |
Application Number: | 15/225,594 |
Patent Claims: | see list of patent claims |
Details for Patent 10,113,000
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | See Plans and Pricing | 2018-08-11 |
Genentech, Inc. | RITUXAN HYCELA | rituximab and hyaluronidase human | Injection | 761064 | 06/22/2017 | See Plans and Pricing | 2018-08-11 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |